BUSINESS FINANCE AUTHORITY
NOTICE AND AGENDA
The regular meeting of the Board of Directors is scheduled for
Tuesday, August 22, 2023, at 2:00 PM, 135 N. State St, Concord, New Hampshire.
- Introduction of Board Members.
- Approval of Board of Director Minutes for the Meeting of June 19, 2023.
- Approval of Board of Directors Sealed Nonpublic Minutes of June 19, 2023.
- Revision of Board of Directors 11/21/2022 Minutes
Approve SEDC loan request for $2,500,000 SSBCI Supported ALDO LOC
5. Nonpublic Session for Consideration of Loan and Credits, as applicable.
6. Approval of Items and associated Resolutions from nonpublic session, as applicable.
7. Financial Reports– Chris Kreidermacher
Month End June 2023
FY 2023 – Year End Review
Month End July 2023
8. Lending Reports – Jeremy Stanizzi
CAP Monthly – June/July 2023
CAP Quarterly Report – June 2023
CAP Statistics/Demographics –July 2023
Capacity Report – July 2023
CAP Loss Report
9. Review of Regenerative Medicine Student Loan Forgiveness Program.
10. Executive Director’s Report.
11. Other Business.
BFA BOARD OF DIRECTORS MINUTES
The meeting of the Board of Directors of the Business Finance Authority (“BFA”) was called to order at 2:02 P.M. by Chairman Anagnost at 135 N. State Street, Concord, New Hampshire. The following Directors were present:
Dick Anagnost, Matthew Benson, Stephen Duprey, Nancy Merrill, Jason Syversen, Jeff Hayes, and Catherine Provencher. Also present were: James Key-Wallace, Executive Director and Clerk; Jeremy Stanizzi, Senior Credit Officer; Chris Kreidermacher, Chief Financial Officer; Jeff Cook, Credit Analyst; Deborah Intonti, Executive Assistant, John Stoecker, National Finance Authority, Senator Keith Murphy and Representative Michael Edgar.
Absent were: Director Monica Mezzapelle, Director Charles Withee, Representative Laurie Sanborn, Director Daniel Henderson and Senator Lou D’Alessandro.
Chairman Anagnost announced the meeting was open to the public and welcomed all present.
The Chairman asked for approval of the public and sealed nonpublic Board minutes for the June 19, 2023, Board Meeting.
Upon motion made by Director Benson and seconded by Director Merrill the following action was voted on:
VOTED: To accept the public and sealed nonpublic minutes of the June 19, 2023, Board Meeting.
The following named Directors voted:
Aye: Matthew Benson, Stephen Duprey, Nancy Merrill, Jason Syversen, and Jeff Hayes.
Nay: None
Abstain: Catherine Provencher, Dick Anagnost.
Whereupon the Chairman declared said resolution adopted.
The Chairman asked for approval of the revised public Board minutes for the November 21, 2022, Board Meeting.
Upon motion made by Director Duprey and seconded by Director Provencher the following action was voted on:
VOTED: To accept the revised public minutes of the November 21, 2022, Board Meeting.
The following named Directors voted:
Aye: Stephen Duprey, Dick Anagnost, Nancy Merrill, and Catherine Provencher.
Nay: None
Abstain: Jason Syversen, Jeff Hayes, Matt Benson
Whereupon the Chairman declared said resolution adopted.
The Chairman asked Chris Kreidermacher to review the June and July Month End Financial Reports.
The Chairman asked Chris Kreidermacher to review the FY 2023 Year-End Review.
The Chairman asked Mr. Stanizzi to review the Lending Reports for June and July
The Chairman asked Mr. Key-Wallace to discuss the Review of Regenerative Medicine Student Loan Forgiveness Program.
The Chairman asked Mr. Key-Wallace to present the Executive Director’s Report.
There being no further business and upon motion made by Director Benson and seconded by
Director Provencher, the meeting was adjourned at 2:59 p.m.
Respectfully submitted:
James Key-Wallace
Executive Director/Clerk